June 2007
Beginner to intermediate
950 pages
27h 8m
English
The median age at death was one week later in the October cohort, but look at the width of the confidence intervals: 3 to 9 versus 2 to 7. Clearly there is no significant effect of cohort on time of death. What about gap size? We start with a full analysis of covariance using coxph rather than survfit.
model1<-coxph(Surv(death,status)~strata(cohort)*gapsize) summary(model1) Call: coxph(formula = Surv(death, status) - strata(cohort) * gapsize) n= 60
coef exp(coef) se(coef) z p
gapsize -1.19 0.305 0.621 -1.910 0.056
gapsize:strata(cohort) 0.58 1.785 0.826 0.701 0.480
cohort=September
exp(coef) exp(-coef) lower .95 upper .95
gapsize 0.305 3.27 0.0904 1.03
gapsize:strata(cohort) 1.785 0.56 0.3534 9.02
cohort=September
Rsquare= 0.076 (max possible= 0.993 )
Likelihood ratio test= 4.73 on 2 df, p=0.0937
Wald test = 4.89 on 2 df, p=0.0868
Score (logrank) test = 5.04 on 2 df, p=0.0805
There is no evidence of any interaction (p = 0.480) and the main effect of gap size is not quite significant in this model (p = 0.056). We fit the simpler model with no interaction:
model2<-coxph(Surv(death,status)~strata(cohort)+gapsize) anova(model1,model2) Analysis of Deviance Table Model 1: Surv(death, status)~ strata(cohort) * gapsize Model 2: Surv(death, status)~ strata(cohort) + gapsize Resid. Df Resid. Dev Df Deviance 1 58 293.898 2 59 294.392 -1 -0.494
There is no significant difference in explanatory power, so we accept the simpler model without an interaction term. ...
Read now
Unlock full access